RealSeq Biosciences Awarded NIH SBIR Phase II Grant to Advance Breakthrough RNA Fragmentomics Platform
RiboMarker-NextGen Biomarker Discovery SANTA CRUZ, CA, UNITED STATES, September 17, 2025 /EINPresswire.com/ -- RealSeq Biosciences, a pioneer in RNA-based diagnostics, today announced it has received a Phase II Small Business Innovation Research (SBIR) …